RAYMOND JAMES & ASSOCIATES – Eli Lilly and Company Transaction History
RAYMOND JAMES & ASSOCIATES portfolio value:
$211.79M
portfolio value
RAYMOND JAMES & ASSOCIATES quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.15% | -21.27K shares | -7.47M | $323.35 | 654.96K |
| Q2 2022 | share | Decrease | -3.47% | -24.28K shares | 18.65M | $324.23 | 676.23K |
| Q1 2022 | share | Increase | +2.34% | 16.02K shares | 11.53M | $286.37 | 700.51K |
| Q4 2021 | share | Increase | +6.66% | 42.73K shares | 40.79M | $277.25 | 684.49K |
| Q3 2021 | share | Decrease | -14.47% | -108.53K shares | -23.92M | $230.3 | 641.76K |
| Q2 2021 | share | Increase | +11.17% | 75.38K shares | 46.12M | $228.04 | 750.29K |
| Q1 2021 | share | Increase | +1.93% | 12.77K shares | 14.29M | $184.81 | 674.91K |
| Q4 2020 | share | Decrease | -6.79% | -48.23K shares | 6.64M | $166.32 | 662.14K |
| Q3 2020 | share | Decrease | -5.54% | -41.65K shares | -18.31M | $145.05 | 710.37K |
| Q2 2020 | share | Decrease | -5.00% | -39.56K shares | 13.65M | $160.1 | 752.02K |
| Q1 2020 | share | Increase | +15.20% | 104.46K shares | 19.50M | $134.64 | 791.59K |
| Q4 2019 | share | Increase | +1.08% | 7.33K shares | 14.28M | $126.91 | 687.12K |
| Q3 2019 | share | Increase | +50.94% | 229.42K shares | 26.12M | $107.36 | 679.78K |
| Q2 2019 | share | Decrease | -12.61% | -64.97K shares | -16.97M | $105.74 | 450.36K |
| Q1 2019 | share | Decrease | -1.12% | -5.85K shares | 6.56M | $123.17 | 515.34K |
| Q4 2018 | share | Increase | +15.26% | 68.99K shares | 11.78M | $109.26 | 521.19K |
| Q3 2018 | share | Increase | +3.97% | 17.28K shares | 11.41M | $100.8 | 452.19K |
| Q2 2018 | share | Increase | +13.43% | 51.50K shares | 7.44M | $79.72 | 434.91K |
| Q1 2018 | share | Decrease | -2.34% | -9.18K shares | -3.49M | $71.78 | 383.41K |
| Q4 2017 | share | Increase | +7.52% | 27.46K shares | 1.92M | $77.79 | 392.59K |
| Q3 2017 | call | Decrease | -100.00% | -15.9K shares | -31K | $78.29 | 0 |
| Q3 2017 | share | Increase | +2.73% | 9.70K shares | 1.98M | $78.29 | 365.12K |
| Q2 2017 | share | Decrease | -6.42% | -24.4K shares | -2.69M | $74.85 | 355.42K |
| Q2 2017 | call | Decrease | -53.91% | -18.6K shares | -56K | $74.85 | 15.9K |
| Q1 2017 | share | Decrease | -7.90% | -32.57K shares | 1.61M | $76 | 379.82K |
| Q1 2017 | call | Increase | +20.63% | 5.9K shares | -32K | $76 | 34.5K |
| Q4 2016 | share | Increase | +0.05% | 194 shares | -2.75M | $66.02 | 412.40K |
| Q4 2016 | call | Decrease | -33.18% | -14.2K shares | 98K | $66.02 | 28.6K |
| Q3 2016 | share | Increase | +36.29% | 109.75K shares | 9.26M | $71.57 | 412.20K |
| Q3 2016 | call | Increase | 0.00% | 42.8K shares | 21K | $71.57 | 42.8K |
| Q2 2016 | share | Increase | +9.87% | 27.16K shares | 3.99M | $69.79 | 302.45K |
| Q1 2016 | share | Decrease | -10.59% | -32.62K shares | -6.12M | $63.39 | 275.28K |